For patients living with degenerative spine and joint conditions, the standard course of treatment has long followed a narrow path. Physical therapy and medication manage symptoms for a time, and when pain persists, surgery is often presented as the remaining option. That limited menu of choices has left an opening for regenerative medicine, a field centered on the idea that the body's own cellular repair processes, properly.
y supported, can address damage that conventional treatment is not built to reverse. As the field has grown, it has drawn in an unusual class of leadership: executives who were once patients themselves, and who entered the business only after their own recovery convinced them of its value.
